May 16, 2012
From the Healthcare & Life Sciences Institute
This is a summary report of risk and disclosure by the major pharmaceutical and life sciences companies.
The report highlights the significant business risk factors disclosed by leading pharmaceutical and other life sciences companies in their 2011 annual reports and financial statements.
These risk factors serve to alert shareholders or potential shareholders to those factors that could materially alter a company’s performance and financial circumstances.
We have reviewed the most recent relevant filing of the 34 largest pharmaceutical and other life sciences companies and considered their quantitative and qualitative disclosures.